Recruiting
Basic and Clinical Research of Pregnancy-Induced Hypertension
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
ClinicalTrials.gov IDNCT07464379
PhaseNot Applicable
Enrollment100
SponsorSecond Affiliated Hospital of Wenzhou Medical University
Age20 Years
SexFEMALE
Conditions studied
Pregnancy-induced Hypertension
About this study
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
Interventions
- Other: no Intervention — observation
Primary outcomes
- PIH (Early pregnancy：Weeks 1 to 12 (the first to third months of pregnancy) ；mid-pregnancy：Weeks 13 to 27 (the 4th to 6th month of pregnancy) ；post-delivery period：Weeks 28 to 40 (the 7th to 9th months of pregnancy)；the day of delivery。)
Eligibility information
Inclusion Criteria:
\- Healthy pregnant women, patients with miscarriage, etc.
Exclusion Criteria:
* Heart disease, infections, etc. in pregnant women Uncooperative patients
Study locations
- The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.